Pierre Deltenre

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


103 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999 | 1997 | 1996 | 1995 | 1994 |
 
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Strnad P., Buch S., Hamesch K., Fischer J., Rosendahl J., Schmelz R., Brueckner S., Brosch M., Heimes C.V., Woditsch V. et al., 2019/06. Gut, 68 (6) pp. 1099-1107. Peer-reviewed.
 
Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion.
Marot A., Barbosa J.V., Duran R., Deltenre P., Denys A., 2019/03. Diagnostic and interventional imaging, 100 (3) pp. 147-156. Peer-reviewed.
 
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F., Buch S., Nischalke H.D., Weiss K.H., Gotthardt D., Fischer J., Rosendahl J., Marot A., Elamly M., Casper M. et al., 2018/10. The American journal of gastroenterology, 113 (10) pp. 1475-1483. Peer-reviewed.
 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis.
Marot A., Henrion J., Knebel J.F., Deltenre P., 2018/10. Journal of hepatology, 69 (4) pp. 975-976. Peer-reviewed.
 
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis.
Stickel F., Buch S., Nischalke H.D., Weiss K.H., Gotthardt D., Fischer J., Rosendahl J., Marot A., Elamly M., Casper M. et al., 2018/07..
 
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N., Duran R., Guiu B., Cercueil J.P., Aubé C., Digklia A., Pache I., Deltenre P., Knebel J.F., Denys A., 2018/05. The lancet. Gastroenterology & hepatology, 3 (5) pp. 317-325. Peer-reviewed.
 
Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.
Leporq B., Daire J.L., Pastor C.M., Deltenre P., Sempoux C., Schmidt S., Van Beers B.E., 2018/04/16. Clinical science, 132 (7) pp. 813-824. Peer-reviewed.
 
Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
Trépo E., Goossens N., Fujiwara N., Song W.M., Colaprico A., Marot A., Spahr L., Demetter P., Sempoux C., Im G.Y. et al., 2018/03. Gastroenterology, 154 (4) pp. 965-975. Peer-reviewed.
Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
Marot A., Dubois M., Trépo E., Moreno C., Deltenre P., 2018. PloS one, 13 (1) pp. e0190823. Peer-reviewed.
 
Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
Marot A., Belaid A., Orlent H., Sersté T., Michielsen P., Colle I., Laleman W., de Galocsy C., Reynaert H., D'Heygere F. et al., 2017/12. Clinics and research in hepatology and gastroenterology, 41 (6) pp. 656-663. Peer-reviewed.
 
Syndrome hépato-pulmonaire et hypertension porto-pulmonaire [Hepatopulmonary syndrome and portopulmonary hypertension]
Marcu C., Schiffer E., Aubert J.D., Vionnet J., Yerly P., Deltenre P., Marot A., 2017/08/30. Revue medicale suisse, 13 (572) pp. 1464-1469. Peer-reviewed.
 
Effect of abstinence on the prognosis of patients with alcoholic liver disease: A word of caution.
Deltenre P., Marot A., Knebel J.F., Doerig C., Henrion J., Moreno C., 2017/06. Journal of hepatology, 66 (6) pp. 1329-1330. Peer-reviewed.
 
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A., Trebicka J., Klinger C., Plessier A., Seijo S., Terziroli B., Magenta L., Semela D., Buscarini E., Langlet P. et al., 2017/05. Liver international : official journal of the International Association for the Study of the Liver, 37 (5) pp. 694-699. Peer-reviewed.
 
Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding.
Marot A., Trépo E., Doerig C., Schoepfer A., Moreno C., Deltenre P., 2017/05. Liver international, 37 (5) pp. 707-716. Peer-reviewed.
 
RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Duran R., Deltenre P., Denys A., 2017/05. Gastroenterology, 152 (6) pp. 1625-1626. Peer-reviewed.
 
External validation of the nomogram for individualized prediction of hepatocellular carcinoma occurrence in patients with hepatitis C virus-related compensated cirrhosis.
Marot A., Vandenbulcke H., Knebel J.F., Doerig C., Moreno C., Deltenre P., 2017/04. Hepatology, 65 (4) pp. 1419-1421. Peer-reviewed.
 
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
Monier A., Guiu B., Duran R., Aho S., Bize P., Deltenre P., Dunet V., Denys A., 2017/04. European radiology, 27 (4) pp. 1431-1439. Peer-reviewed.
 
Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.
Schoepfer A.M., Vavricka S., Safroneeva E., Fournier N., Manser C., Frei P., Deltenre P., Rogler G., Straumann A., Ezri J. et al., 2017/02. Journal of pediatric gastroenterology and nutrition, 64 (2) pp. 245-247. Peer-reviewed.
Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A., Henrion J., Knebel J.F., Moreno C., Deltenre P., 2017. PloS one, 12 (10) pp. e0186715. Peer-reviewed.
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
Bruggmann P., Blach S., Deltenre P., Fehr J., Kouyos R., Lavanchy D., Müllhaupt B., Rauch A., Razavi H., Schmid P. et al., 2017. Swiss medical weekly, 147 pp. w14543. Peer-reviewed.
Self-expanding metal stent should be considered in patients with cirrhosis and uncontrolled variceal bleeding.
Marot A., Trépo E., Doerig C., Moreno C., Deltenre P., 2016/12. Hepatology, 64 (6) p. 2273. Peer-reviewed.
 
Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.
Vandenbulcke H., Moreno C., Colle I., Knebel J.F., Francque S., Sersté T., George C., de Galocsy C., Laleman W., Delwaide J. et al., 2016/09. Journal of hepatology, 65 (3) pp. 543-551. Peer-reviewed.
 
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs.
Arain A., Bourgeois S., de Galocsy C., Henrion J., Deltenre P., d'Heygere F., George C., Bastens B., Van Overbeke L., Verrando R. et al., 2016. Journal of Medical Virology, 88 (1) pp. 94-99.
 
Insulin resistance is associated with esophageal varices in alcoholic liver disease patients.
Degré D., Gustot T., Gerkens A., Boon N., Schreiber J., Lepida A., Sersté T., Deltenre P., Devière J., Trépo E. et al., 2016. European Journal of Gastroenterology and Hepatology, 28 (7) pp. 792-796. Peer-reviewed.
 
Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.
Moreno C., Deltenre P., Senterre C., Louvet A., Gustot T., Bastens B., Hittelet A., Piquet M.A., Laleman W., Orlent H. et al., 2016. Gastroenterology, 150 (4) pp. 903-910.e8. Peer-reviewed.
 
Reply.
Deltenre P., Trepo E., Moreno C., 2016. Gastroenterology, 151 (2) p. 377. Peer-reviewed.
 
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.
Buch S., Stickel F., Trépo E., Way M., Herrmann A., Nischalke H.D., Brosch M., Rosendahl J., Berg T., Ridinger M. et al., 2015. Nature Genetics, 47 (12) pp. 1443-1448. Peer-reviewed.
 
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials.
Deltenre P., Trépo E., Rudler M., Monescillo A., Fraga M., Denys A., Doerig C., Fournier N., Moreno C., Moradpour D. et al., 2015. European Journal of Gastroenterology and Hepatology, 27 (9) pp. e1-e9. Peer-reviewed.
 
Facteurs impliqués dans le développement et la progression de la maladie aLcoolique du foie [Factors influencing development and progression of alcoholic liver disease].
Abdelrahman K., Marot A., Deltenre P., 2015. Revue Médicale Suisse, 11 (484) pp. 1604-1607.
 
Studies on the epidemiology of hepatitis B and C virus infections are still needed.
Deltenre P., 2015. Journal of Hepatology, 62 (6) pp. 1225-1227.
 
Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.
Marot A., Trépo E., Doerig C., Moreno C., Moradpour D., Deltenre P., 2015. Alimentary Pharmacology and Therapeutics, 42 (11-12) pp. 1250-1260. Peer-reviewed.
 
The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.
Sersté T., Njimi H., Degré D., Deltenre P., Schreiber J., Lepida A., Trépo E., Gustot T., Moreno C., 2015. Liver International : Official Journal of the International Association For the Study of the Liver, 35 (8) pp. 1974-1982. Peer-reviewed.
 
A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE).
Bourgeois S., Deltenre P., Delwaide J., Henrion J., Adler M., Langlet P., Mulkay J.P., Nevens F., Brixko C., Moreno C., 2014. Acta Gastro-enterologica Belgica, 77 (4) pp. 393-400. Peer-reviewed.
 
Actualités diagnostiques et thérapeutiques dans le domaine de l'encéphalopathie hépatique [Hepatic encephalopathy: recent developments].
Deltenre P., Moradpour D., 2014. Revue Médicale Suisse, 10 (440) pp. 1612, 1614-1612, 1616.
 
Actualités en gastroentérologie et hépatologie [Highlights in gastroenterology and hepatology 2013].
Hessler R., Godat S., Fraga M., Burgmann K., Doerig C., Deltenre P., Schoepfer A., 2014. Revue Médicale Suisse, 10 (412-413) pp. 41-44.
 
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.
Trépo E., Nahon P., Bontempi G., Valenti L., Falleti E., Nischalke H.D., Hamza S., Corradini S.G., Burza M.A., Guyot E. et al., 2014. Hepatology, 59 (6) pp. 2170-2177. Peer-reviewed.
 
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: A modelling approach.
Deuffic-Burban S., Mathurin P., Rosa I., Bouvier A.M., Cannesson A., Mourad A., Canva V., Louvet A., Deltenre P., Boleslawski E. et al., 2014. Digestive and Liver Disease, 46 (2) pp. 157-163.
 
Reply: To PMID 24114809.
Romeo S., Valenti L., Trépo E., Moreno C., Nahon P., Deltenre P., 2014. Hepatology (baltimore, Md.), 60 (3) pp. 1111-1112.
 
Response to the letter of Chitsaz et al. 'The role of proton pump inhibitors in the occurrence of spontaneous bacterial peritonitis'.
de Vos M., Henrion J., Deltenre P., 2014. Liver International, 34 (6) pp. 964-965. Peer-reviewed.
 
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Deuffic-Burban S., Schwarzinger M., Obach D., Mallet V., Pol S., Pageaux G.P., Canva V., Deltenre P., Roudot-Thoraval F., Larrey D. et al., 2014. Journal of Hepatology, 61 (1) pp. 7-14. Peer-reviewed.
 
Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
Ho E., Deltenre P., Nkuize M., Delwaide J., Colle I., Michielsen P., Belgian Association for the Study of the Liver, 2013. Journal of Medical Virology, 85 (9) pp. 1513-1517.
 
Decompensated cirrhosis ... are we gaining ground?
Henrion J., Deltenre P., 2013. Acta Clinica Belgica, 68 (6) pp. 411-415. Peer-reviewed.
 
Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
De Vroey B., Moreno C., Laleman W., van Gossum M., Colle I., de Galocsy C., Langlet P., Robaeys G., Orlent H., Michielsen P. et al., 2013. European Journal of Gastroenterology and Hepatology, 25 (5) pp. 613-619.
 
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E., Ouziel R., Pradat P., Momozawa Y., Quertinmont E., Gervy C., Gustot T., Degré D., Vercruysse V., Deltenre P. et al., 2013. Journal of Hepatology, 59 (2) pp. 344-350.
 
Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M., De Vroey B., Garcia B.G., Roy C., Kidd F., Henrion J., Deltenre P., 2013. Liver International, 33 (9) pp. 1316-1323.
 
Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.
Nahon S., Hagège H., Latrive J.P., Rosa I., Nalet B., Bour B., Faroux R., Gower P., Arpurt J.P., Denis J. et al., 2012. Endoscopy, 44 (11) pp. 998-1008.
 
Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patients.
Zeitoun J.D., Rosa-Hézode I., Chryssostalis A., Nalet B., Bour B., Arpurt J.P., Denis J., Nahon S., Pariente A., Hagège H. et al., 2012. Clinics and Research in Hepatology and Gastroenterology, 36 (3) pp. 227-234.
 
HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers.
Deltenre P., Laleman W., Van Gossum M., Lenaerts A., Colle I., Michielsen P., Adler M., Delwaide J., Assene C., Reynaert H. et al., 2012. Acta Gastro-enterologica Belgica, 75 (1) pp. 35-41.
 
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.
Boleslawski E., Petrovai G., Truant S., Dharancy S., Duhamel A., Salleron J., Deltenre P., Lebuffe G., Mathurin P., Pruvot F.R., 2012. British Journal of Surgery, 99 (6) pp. 855-863.
 
Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients.
Schreiber J., Moreno C., Garcia B.G., Louvet A., Trepo E., Henrion J., Thabut D., Mathurin P., Deltenre P., 2012. Alimentary Pharmacology and Therapeutics, 36 (4) pp. 353-362.
 
Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S., Deltenre P., Buti M., Stroffolini T., Parkes J., Mühlberger N., Siebert U., Moreno C., Hatzakis A., Rosenberg W. et al., 2012. Gastroenterology, 143 (4) pp. 974-85.e14.
 
Prise en charge de l'hépatite C chronique en 2012 en Belgique [Management of chronic hepatitis C in 2012 in Belgium].
Moreno C., Deltenre P., 2012. Revue Médicale de Bruxelles, 33 (4) pp. 223-227.
 
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
Orlent H., Deltenre P., Francque S., Laleman W., Moreno C., Bourgeois S., Colle I., Delwaide J., De Maeght S., Mulkay J.P. et al., 2012. Acta Gastro-enterologica Belgica, 75 (2) pp. 245-259.
 
Acute lower limb ischemia as a triggering condition in hypoxic hepatitis: a study of five cases.
Henrion J., Deltenre P., De Maeght S., Peny M.O., Schapira M., 2011. Journal of Clinical Gastroenterology, 45 (3) pp. 274-277.
 
Acute upper gastrointestinal bleeding in cirrhosis: changes and advances over the past two decades.
Henrion J., Deltenre P., De Maeght S., Ghilain J.M., Maisin J.M., Moulart M., Delaunoit T., Verset D., Yeung R., Schapira M., 2011. Acta Gastro-enterologica Belgica, 74 (3) pp. 381-388.
 
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
Deltenre P., Moreno C., Tran A., Ollivier I., Provôt F., Stanke F., Lazrek M., Castel H., Canva V., Louvet A. et al., 2011. Alimentary Pharmacology and Therapeutics, 34 (4) pp. 454-461.
 
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.
Trépo E., Gustot T., Degré D., Lemmers A., Verset L., Demetter P., Ouziel R., Quertinmont E., Vercruysse V., Amininejad L. et al., 2011. Journal of Hepatology, 55 (4) pp. 906-912.
 
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.
Francque S., De Maeght S., Adler M., Deltenre P., de Galocsy C., Orlent H., Van Steenbergen W., Bastens B., Wain E., Langlet P. et al., 2011. Acta Gastro-enterologica Belgica, 74 (1) pp. 9-16.
 
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
Deltenre P., Louvet A., Lemoine M., Mourad A., Fartoux L., Moreno C., Henrion J., Mathurin P., Serfaty L., 2011. Journal of Hepatology, 55 (6) pp. 1187-1194.
 
Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.
Deltenre P., Corouge M., Canva V., Castel H., Wartel F., Dharancy S., Louvet A., Lazrek M., Moreno C., Henrion J. et al., 2011. Journal of Hepatology, 55 (5) pp. 989-995.
 
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.
Plessier A., Darwish-Murad S., Hernandez-Guerra M., Consigny Y., Fabris F., Trebicka J., Heller J., Morard I., Lasser L., Langlet P. et al., 2010. Hepatology, 51 (1) pp. 210-218.
 
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.
Melin P., Chousterman M., Fontanges T., Ouzan D., Rotily M., Lang J.P., Marcellin P., Cacoub P., CheObs Study Group, 2010. European Journal of Gastroenterology and Hepatology, 22 (9) pp. 1050-1057.
 
Fatal hypoxic hepatitis in a patient with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber's disease).
Henrion J., Deltenre P., Peny M.O., Dumoulin P., Laurent Y., Brenard R., 2010. Acta Gastro-enterologica Belgica, 73 (1) pp. 61-64.
 
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.
Brenard R., Chapaux X., Deltenre P., Henrion J., De Maeght S., Horsmans Y., Borbath I., Leenaerts A., Van Cauter J., Francque S. et al., 2010. European Journal of Gastroenterology and Hepatology, 22 (10) pp. 1253-1259.
 
Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis.
Moreno C., Deltenre P., Pawlotsky J.M., Henrion J., Adler M., Mathurin P., 2010. Journal of Hepatology, 52 (1) pp. 25-31.
 
A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study.
Deltenre P., Canva V., El Nady M., François C., Castelain S., Dharancy S., Louvet A., Bocket L., Lazrek M., Hollebecque A. et al., 2009. Journal of Viral Hepatitis, 16 (7) pp. 500-505.
 
Acute hepatitis induced by glatiramer acetate.
Deltenre P., Peny M.O., Dufour A., Nady M.E., Henrion J., 2009. Bmj Case Reports, 2009 p. 2009. Peer-reviewed.
 
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
Peyrin-Biroulet L., Deltenre P., Ardizzone S., D'Haens G., Hanauer S.B., Herfarth H., Lémann M., Colombel J.F., 2009. American Journal of Gastroenterology, 104 (8) pp. 2089-2096.
 
Effect of binge drinking on the liver: an alarming public health issue?
Mathurin P., Deltenre P., 2009. Gut, 58 (5) pp. 613-617.
 
Epidémiologie de la maladie alcoolique et nouveaux enjeux [Epidemiology of alcoholic liver disease and new challenges].
Deltenre P., Mathurin P., 2009. Gastroentérologie Clinique et Biologique, 33 (12) pp. 1147-1150.
 
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
Deuffic-Burban S., Babany G., Lonjon-Domanec I., Deltenre P., Canva-Delcambre V., Dharancy S., Louvet A., Roudot-Thoraval F., Mathurin P., 2009. Hepatology, 50 (5) pp. 1351-1359.
 
Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A., Wartel F., Castel H., Dharancy S., Hollebecque A., Canva-Delcambre V., Deltenre P., Mathurin P., 2009. Gastroenterology, 137 (2) pp. 541-548.
 
Virological tools for optimal management of chronic hepatitis C.
Deltenre P., 2009. Acta Gastro-enterologica Belgica, 72 (4) pp. 421-424.
 
Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
Louvet A., Diaz E., Dharancy S., Coevoet H., Texier F., Thévenot T., Deltenre P., Canva V., Plane C., Mathurin P., 2008. Journal of Hepatology, 48 (3) pp. 465-470.
 
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.
Peyrin-Biroulet L., Deltenre P., de Suray N., Branche J., Sandborn W.J., Colombel J.F., 2008. Clinical Gastroenterology and Hepatology, 6 (6) pp. 644-653.
 
Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France.
Deuffic-Burban S., Deltenre P., Louvet A., Canva V., Dharancy S., Hollebecque A., Boitard J., Henrion J., Yazdanpanah Y., Mathurin P., 2008. Journal of Hepatology, 49 (2) pp. 175-183.
 
NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?
Grisart B., Rack K., Vidrequin S., Hilbert P., Deltenre P., Verellen-Dumoulin C., Destrée A., 2008. European Journal of Human Genetics, 16 (3) pp. 305-311.
 
Upper gastrointestinal bleeding: what has changed during the last 20 years?
Henrion J., Schapira M., Ghilain J.M., Maisin J.M., De maeght S., Deltenre P., Moulart M., Delaunoit T., 2008. Gastroentérologie Clinique et Biologique, 32 (10) pp. 839-847.
 
Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
Horsmans Y., Colle I., Van Vlierberghe H., Langlet P., Adler M., Bourgeois N., Brenard R., Michielsen P., Goossens A., Bruckers L. et al., 2008. Acta Gastro-enterologica Belgica, 71 (3) pp. 293-297.
 
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
Louvet A., Naveau S., Abdelnour M., Ramond M.J., Diaz E., Fartoux L., Dharancy S., Texier F., Hollebecque A., Serfaty L. et al., 2007. Hepatology, 45 (6) pp. 1348-1354.
 
Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis.
Louvet A., Texier F., Dharancy S., Pruvot F.R., Sergent G., Deltenre P., Ernst O., Paris J.C., Mathurin P., 2006. Digestive Diseases and Sciences, 51 (1) pp. 11-17.
 
Extensive portal vein thrombosis related to abdominal trauma.
Gonzalez F., Condat B., Deltenre P., Mathurin P., Paris J.C., Dharancy S., 2006. Gastroentérologie Clinique et Biologique, 30 (2) pp. 314-316.
 
Ischemic cholangiopathy.
Deltenre P., Valla D.C., 2006. Journal of Hepatology, 44 (4) pp. 806-817.
 
La mésaventure thérapeutique du paracétamol chez le buveur excessif [Problems with therapeutic acetaminophen use in excessive drinkers].
Louvet A., Boitard J., Dharancy S., Duriez A., Deltenre P., Paris J.C., Mathurin P., 2006. Gastroentérologie Clinique et Biologique, 30 (5) pp. 769-774.
 
The evolution of severe steatosis after bariatric surgery is related to insulin resistance.
Mathurin P., Gonzalez F., Kerdraon O., Leteurtre E., Arnalsteen L., Hollebecque A., Louvet A., Dharancy S., Cocq P., Jany T. et al., 2006. Gastroenterology, 130 (6) pp. 1617-1624.
 
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites.
Deltenre P., Lebrec D., Mathurin P., 2006. Gastroenterology, 130 (4) pp. 1372-3; author reply 1373.
 
Principes de prise en charge des complications des malades cirrhotiques [Managing the complications of cirrhosis].
Deltenre P., Mathurin P., Barraud H., Bronowicki J.P., Jacquet E., Puche P., Jaber S., Navarro F., Pageaux G.P., 2005. Revue du Praticien, 55 (14) pp. 1555-1563.
 
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.
Deltenre P., Mathurin P., Dharancy S., Moreau R., Bulois P., Henrion J., Pruvot F.R., Ernst O., Paris J.C., Lebrec D., 2005. Liver International, 25 (2) pp. 349-356.
 
Abcès hépatique multilobulé à Streptocoque Bovis [Multilobular liver abscess due to Streptococcus bovis].
Espeel B., Caulry C., Deltenre P., Mansvelt B., Vermonden J., 2004. Journal de Chirurgie, 141 (6) pp. 404-405.
 
Evaluation of amantadine in chronic hepatitis C: a meta-analysis.
Deltenre P., Henrion J., Canva V., Dharancy S., Texier F., Louvet A., De Maeght S., Paris J.C., Mathurin P., 2004. Journal of Hepatology, 41 (3) pp. 462-473.
 
Hépatite alcoolique: données physiopathologiques et perspectives thérapeutiques [Alcoholic hepatitis: pathophysiological data and therapeutic perspectives].
Mathurin P., Dharancy S., Malapel M., Deltenre P., Texier F., Paris J.C., 2004. Gastroentérologie Clinique et Biologique, 28 (5 Suppl) pp. D103-D111.
 
Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alcoolique [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
Henrion J., Libon E., De Maeght S., Deltenre P., Schapira M., Ghilain J.M., Maisin J.M., Heller F.R., 2003. Gastroentérologie Clinique et Biologique, 27 (5) pp. 534-539.
 
Epidemiology of coeliac disease.
Schapira M., Maisin J.M., Ghilain J.M., De Maeght S., Deltenre P., Henrion J., 2003. Acta Gastro-enterologica Belgica, 66 (3) pp. 234-236.
 
Impact of hepatitis C virus infection on the aetiology of cirrhosis and hepatocarcinoma in three affiliated hospitals in southern Belgium.
Henrion J., De Maeght S., Deltenre P., Ghilain J.M., Maisin J.M., Schapira M., Heller F., 2002. Acta Gastro-enterologica Belgica, 65 (2) pp. 80-82.
 
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis.
Deltenre P., Rufat P., Hillaire S., Elman A., Moreau R., Valla D., Lebrec D., 2002. American Journal of Gastroenterology, 97 (5) pp. 1187-1190.
 
Factor V Leiden related Budd-Chiari syndrome.
Deltenre P., Denninger M.H., Hillaire S., Guillin M.C., Casadevall N., Brière J., Erlinger S., Valla D.C., 2001. Gut, 48 (2) pp. 264-268.
 
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose.
Moreau R., Chagneau C., Heller J., Chevenne D., Langlet P., Deltenre P., Hillaire S., Lefilliatre P., Pateron D., Sogni P. et al., 2001. Scandinavian Journal of Gastroenterology, 36 (3) pp. 303-308.
 
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis.
Deltenre P., Berson A., Marcellin P., Degott C., Biour M., Pessayre D., 1999. Gut, 44 (6) pp. 886-888.
 
Lymphangiome kystique bénin chez un patient atteint de porphyrie aiguë intermittente [Benign cystic lymphangioma in a patient with acute intermittent porphyria].
Deltenre P., Willocx R., Van Vyve E., 1997. Gastroentérologie Clinique et Biologique, 21 (3) pp. 229-231.
 
An unusual cause for left sided colitis: hot-water enema.
Schapira M., Gerard R., Deltenre P., Henrion J., Ghilain J.M., Maisin J.M., Schmitz A., Heller F.R., 1996. Acta Gastro-enterologica Belgica, 59 (3) pp. 220-221.
 
Allongement majeur de l'intervalle QT observée lors d'une embolie pulmonaire massive [Major prolongation of the QT interval observed in the course of massive pulmonary embolism].
de Meester A., Deltenre P., Chaudron J.M., 1995. Acta Clinica Belgica, 50 (5) pp. 301-304.
 
Le rapport L/A permet-il d'identifier les pancréatites aiguës alcooliques [Can the L/A ratio identify acute alcoholic pancreatitis?].
Deltenre P., Ghilain J.M., Maisin J.M., Schapira M., Henrion J., Heller F.R., 1995. Acta Gastro-enterologica Belgica, 58 (2) pp. 222-229.
 
Hépatite toxique due à la prise d'ecstasy: rapport d'un cas probable et revue de la littérature [Toxic hepatitis due to ecstasy administration: report of a possible case and literature review].
Deltenre P., Henrion J., Jacques J.M., Schapira M., Ghilain J.M., Maisin J.M., Heller F.R., 1994. Acta Gastro-enterologica Belgica, 57 (5-6) pp. 341-345.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University